Himed and Lithoz Announce Launch of New Bioceramics Center of Excellence™
Himed and Lithoz are pleased to announce the launch of a new Bioceramics Center of Excellence™ (BCoE) at Himed's New York headquarters. The BCoE will offer a holistic approach to bioceramics R&D for medical device manufacturers, integrating various analytical services to support rapid prototyping and device customization.
Global Biomaterials Manufacturer Himed Announces Leadership Transition in 2024
Craig Rosenblum has been appointed as the new President of Himed. He succeeds Ed Garofalo, who will be transitioning into the advisory position of President Emeritus. Rosenblum’s guidance has helped propel Himed to achieve remarkable milestones and solidified its position as an industry leader in biomaterials for medical devices, leading to his promotion. Having joined the company in 2015, he has seamlessly transitioned through three distinct roles…
My company wants to buy hydroxyapatite from a new supplier—will it be the same as what we’ve been using?
There is no single form of hydroxyapatite (HA, or HAp) that is used universally for all applications, so the short answer is no.
But that doesn’t mean that you can’t find a suitable equivalent, or even a better form, based on your intended application. With so many uses now for hydroxyapatite across a wide range of industries, it’s safe to assume that every company has unique needs and requirements that must be met when sourcing a new vendor.
Himed and Mercury Bio Team Up to Develop Unique Osteogenic Materials for Orthopedic Applications
Himed has entered a new realm of research this month with the formalizing of a research and development agreement with Santa Fe, NM-based Mercury Bio.
As a global supplier of calcium phosphate materials and implant surface treatments that support bone repair, Himed wishes to explore the frontiers of organic CaP integrations at the molecular level, and was seeking a partner with promising IP for small particle delivery. We were fortunate to find that partner in Mercury Bio, which has developed a novel advanced drug delivery system that could prove effective at also loading and targeting CaP compounds.
Himed and Lithoz Enter Medical 3D Printing Materials Research Partnership
Advancing 3D-printed medical implants depends on the steady progress of leading-edge printer technologies, as well as the skillful development of the raw materials used in those technologies. Appreciating that these crucial factors must work together, Himed (www.himed.com), a New York-based biomaterials manufacturer serving dental and orthopedic implant markets worldwide, and Lithoz (www.lithoz.com), a global market leader in 3D printing based in Austria, have teamed up to develop new bioceramic feedstocks.